Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid.
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001653:Bile Ducts, Intrahepatic / Q000187:drug effects; D002792:Cholestyramine Resin / Q000008:administration & dosage; D004195:Disease Models, Animal; D005439:Flufenamic Acid / Q000008:administration & dosage; D005461:Fluorine / Q000008:administration & dosage*; D007273:Injections, Intramuscular; D007410:Intestinal Diseases / Q000139:chemically induced*; D007421:Intestine, Small; D008297:Male; D010303:Paromomycin / Q000008:administration & dosage; D051381:Rats; D014456:Ulcer / Q000139:chemically induced; D062367:ortho-Aminobenzoates / Q000008:administration & dosage*
D000893:Anti-Inflammatory Agents; D062367:ortho-Aminobenzoates; D002792:Cholestyramine Resin; D005461:Fluorine; D005439:Flufenamic Acid; D010303:Paromomycin